15-Deoxy-delta 12, 14-prostaglandin J2 attenuates endothelial-monocyte interaction: Implication for inflammatory diseases

Journal of Inflammation

Volumn 5, Issue , 2008, Pages

  Prasad, Ratna ^a   Giri, Shailendra ^a   Singh, Avtar K ^b   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; INFLAMMATORY DISEASE; MONOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSIENT TRANSFECTION;

EID: 51249087115     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-5-14     Document Type: Article

References (57)

1. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. H Ulbrich EE Eriksson L Lindbom, Trends Pharmacol Sci 2003 24 640 647 10.1016/j.tips.2003.10.004 14654305
2. Leukocyte-endothelial adhesion molecules. TM Carlos JM Harlan, Blood 1994 84 2068 2101 7522621
3. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. H Li MI Cybulsky MA Gimbrone Jr P Libby, Am J Pathol 1993 143 1551 1559 7504883
4. Rabbit vascular endothelial adhesion molecules: ELAM-1 is most elevated in acute inflammation, whereas VCAM-1 and ICAM-1 predominate in chronic inflammation. Y Abe K Sugisaki AM Dannenberg Jr, J Leukoc Biol 1996 60 692 703 8975870
5. The blood-brain barrier and multiple sclerosis. AC Moor HE de Vries AG de Boer DD Breimer, Biochem Pharmacol 1994 47 1717 1724 10.1016/0006-2952(94) 90297-6 8204088
6. Adhesion molecule expression and regulation on cells of the central nervous system. SJ Lee EN Benveniste, J Neuroimmunol 1999 98 77 88 10.1016/S0165-5728(99)00084-3 10430040
7. Leukocyte-endothelial cell interactions in the inflammatory response. WA Muller, Lab Invest 2002 82 521 533 10.1038/labinvest.3780446 12003992
8. Immunobiology of human vascular endothelium. JS Pober, Immunol Res 1999 19 225 232 10.1007/BF02786490 10493176
9. TNF signaling in vascular endothelial cells. LA Madge JS Pober, Exp Mol Pathol 2001 70 317 325 10.1006/exmp.2001.2368 11418010
10. Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa B. CC Chen AM Manning, Agents Actions Suppl 1995 47 135 141 7540353
11. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. T Collins MA Read AS Neish MZ Whitley D Thanos T Maniatis, Faseb J 1995 9 899 909 7542214
12. Signaling to NF-kappaB. MS Hayden S Ghosh, Genes Dev 2004 18 2195 2224 10.1101/gad.1228704 15371334
13. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. HC Ledebur TP Parks, J Biol Chem 1995 270 933 943 10.1074/jbc.270.2.933 7822333
14. The nuclear receptor superfamily: the second decade. DJ Mangelsdorf C Thummel M Beato P Herrlich G Schutz K Umesono B Blumberg P Kastner M Mark P Chambon RM Evans, Cell 1995 83 835 839 10.1016/0092-8674(95)90199-X 8521507
15. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. P Tontonoz E Hu BM Spiegelman, Cell 1994 79 1147 1156 10.1016/0092-8674(94)90006-X 8001151
16. Peroxisome proliferator-activated receptors in inflammation control. P Delerive JC Fruchart B Staels, J Endocrinol 2001 169 453 459 10.1677/joe.0.1690453 11375115
17. Emerging roles of PPARs in inflammation and immunity. RA Daynes DC Jones, Nat Rev Immunol 2002 2 748 759 10.1038/nri912 12360213
18. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. SA Kliewer JM Lenhard TM Willson I Patel DC Morris JM Lehmann, Cell 1995 83 813 819 10.1016/0092-8674(95) 90194-9 8521498
19. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. M Ricote AC Li TM Willson CJ Kelly CK Glass, Nature 1998 391 79 82 10.1038/34178 9422508
20. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14- prostaglandin J2. TV Petrova KT Akama LJ Van Eldik, Proc Natl Acad Sci USA 1999 96 4668 4673 10200320 10.1073/pnas.96.8.4668
21. 15-Deoxy-Delta12,1412,14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation. S Vaidya EP Somers SD Wright PA Detmers VS Bansal, J Immunol 1999 163 6187 6192 10570310
22. 15-Deoxy-Delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. JM Kaplan JA Cook PW Hake M O'Connor TJ Burroughs B Zingarelli, Shock 2005 24 59 65 10.1097/01.shk.0000167108.88376.f2 15988322
23. Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. T Genovese S Cuzzocrea R Di Paola E Mazzon C Mastruzzo P Catalano M Sortino N Crimi AP Caputi C Thiemermann C Vancheri, Eur Respir J 2005 25 225 234 10.1183/09031936.05.00049704 15684285
24. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. S Cuzzocrea B Pisano L Dugo A Ianaro NS Patel R Di Paola T Genovese PK Chatterjee M Di Rosa AP Caputi C Thiemermann, Br J Pharmacol 2003 140 366 376 12970094 10.1038/sj.bjp.0705419
25. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. C Natarajan JJ Bright, Genes Immun 2002 3 59 70 10.1038/sj.gene.6363832 11960303
26. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. A Diab C Deng JD Smith RZ Hussain B Phanavanh AE Lovett-Racke PD Drew MK Racke, J Immunol 2002 168 2508 2515 11859145
27. Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B)-nuclear factor-kappa B pathway by lovastatin limits endothelial-monocyte cell interaction. R Prasad S Giri N Nath I Singh AK Singh, J Neurochem 2005 94 204 214 10.1111/j.1471-4159.2005.03182.x 15953363
28. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. JD Dignam RM Lebovitz RG Roeder, Nucleic Acids Res 1983 11 1475 1489 6828386 10.1093/nar/11.5.1475
29. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. S Giri R Rattan AK Singh I Singh, J Immunol 2004 173 5196 5208 15470065
30. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. S Giri N Nath B Smith B Viollet AK Singh I Singh, J Neurosci 2004 24 479 487 10.1523/JNEUROSCI.4288-03.2004 14724246
31. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. N Nath S Giri R Prasad AK Singh I Singh, J Immunol 2004 172 1273 1286 14707106
32. Prostaglandins as modulators of immunity. SG Harris J Padilla L Koumas D Ray RP Phipps, Trends Immunol 2002 23 144 150 10.1016/S1471-4906(01)02154-8 11864843
33. 15d-PGJ2: the anti-inflammatory prostaglandin? JU Scher MH Pillinger, Clin Immunol 2005 114 100 109 10.1016/j.clim.2004.09.008 15639643
34. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. EJ Goetzl S An WL Smith, Faseb J 1995 9 1051 1058 7649404
35. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. A Rossi P Kapahi G Natoli T Takahashi Y Chen M Karin MG Santoro, Nature 2000 403 103 108 10.1038/47520 10638762
36. 15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells. T Imaizumi T Matsumiya W Tamo T Shibata K Fujimoto M Kumagai H Yoshida XF Cui K Tanji M Hatakeyama, Immunol Cell Biol 2002 80 531 536 10.1046/j.1440-1711.2002.01111.x 12406386
37. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. SM Jackson F Parhami XP Xi JA Berliner WA Hsueh RE Law LL Demer, Arterioscler Thromb Vasc Biol 1999 19 2094 2104 10479650
38. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. V Pasceri HD Wu JT Willerson ET Yeh, Circulation 2000 101 235 238 10645917
39. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression. H Migita J Morser, Arterioscler Thromb Vasc Biol 2005 25 710 716 10.1161/01.ATV.0000156482.76228.d1 15662020
40. Protective role of endothelial nitric oxide synthase. EW Albrecht CA Stegeman P Heeringa RH Henning H van Goor, J Pathol 2003 199 8 17 10.1002/path.1250 12474221
41. 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. S Eligini C Banfi M Brambilla M Camera SS Barbieri F Poma E Tremoli S Colli, Thromb Haemost 2002 88 524 532 12353085
42. Role of phosphoinositide 3-kinase in monocyte recruitment under flow conditions. RE Gerszten EB Friedrich T Matsui RR Hung L Li T Force A Rosenzweig, J Biol Chem 2001 276 26846 26851 10.1074/jbc.M011235200 11278864
43. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. ON Ozes LD Mayo JA Gustin SR Pfeffer LM Pfeffer DB Donner, Nature 1999 401 82 85 10.1038/43466 10485710
44. Peroxisome proliferator - activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. H Fahmi JA Di Battista JP Pelletier F Mineau P Ranger J Martel-Pelletier, Arthritis Rheum 2001 44 595 607 10.1002/1529- 0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8 11263774
45. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. Y Kawahito M Kondo Y Tsubouchi A Hashiramoto D Bishop-Bailey K Inoue M Kohno R Yamada T Hla H Sano, J Clin Invest 2000 106 189 197 10903334 10.1172/JCI9652
46. A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. ZZ Shan K Masuko-Hongo SM Dai H Nakamura T Kato K Nishioka, J Biol Chem 2004 279 37939 37950 10.1074/jbc.M402424200 15213234
47. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. A Nakajima K Wada H Miki N Kubota N Nakajima Y Terauchi S Ohnishi LJ Saubermann T Kadowaki RS Blumberg, Gastroenterology 2001 120 460 469 10.1053/gast.2001.21191 11159886
48. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt. B Zingarelli PW Hake P Mangeshkar M O'Connor TJ Burroughs G Piraino A Denenberg HR Wong, Shock 2007 28 554 563 17589386
49. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. CK Combs DE Johnson JC Karlo SB Cannady GE Landreth, J Neurosci 2000 20 558 567 10632585
50. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. MT Heneka T Klockgether DL Feinstein, J Neurosci 2000 20 6862 6867 10995830
51. The cyclopentenone 15-deoxy-delta(12,14)-prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer's disease patients. U Munoz N de Las Cuevas F Bartolome OG Hermida F Bermejo A Martin-Requero, Exp Neurol 2005 195 508 517 10.1016/j.expneurol.2005.06.010 16061222
52. Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. CM Reilly JC Oates JA Cook JD Morrow PV Halushka GS Gilkeson, J Immunol 2000 164 1498 1504 10640767
53. Prostaglandin J(2) inhibition of mesangial cell iNOS expression. CM Reilly JC Oates J Sudian MB Crosby PV Halushka GS Gilkeson, Clin Immunol 2001 98 337 345 10.1006/clim.2000.4985 11237557
54. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2. HP Raikwar G Muthian J Rajasingh CN Johnson JJ Bright, J Neuroimmunol 2006 178 76 86 10.1016/j.jneuroim.2006.05.013 16844232
55. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis. PD Storer J Xu JA Chavis PD Drew, J Neurosci Res 2005 80 66 74 10.1002/jnr.20413 15723383
56. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. H Hirai K Tanaka O Yoshie K Ogawa K Kenmotsu Y Takamori M Ichimasa K Sugamura M Nakamura S Takano K Nagata, J Exp Med 2001 193 255 261 11208866 10.1084/jem.193.2.255
57. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. DS Straus G Pascual M Li JS Welch M Ricote CH Hsiang LL Sengchanthalangsy G Ghosh CK Glass, Proc Natl Acad Sci USA 2000 97 4844 4849 10781090 10.1073/pnas.97.9.4844